Patents by Inventor Harvey J. Alter

Harvey J. Alter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR DETECTING TRANSFUSION-TRANSMITTED PATHOGENS
    Publication number: 20220119898
    Abstract: Probe sets capable of detecting pathogen nucleic acids in a sample are described. The probe set can be provided on a solid support, such as a microarray. Methods of detecting pathogen nucleic acids in a sample using the probe set are also provided. In some examples, the probes and methods are capable of detecting one or more RNA viruses, one or more DNA viruses, one or more bacterial nucleic acids, and/or one or more protozoan nucleic acids in a sample.
    Type: Application
    Filed: January 31, 2020
    Publication date: April 21, 2022
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Valeria De Giorgi, Robert D. Allison, Harvey J. Alter
  • Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
    Patent number: 6924362
    Abstract: The present invention describes the identification and characterization of five human HC E1-specific monoclonal antibodies isolated from a phage display library and their use in the diagnosis, treatment, and prevention of HCV in mammals, preferably humans.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: August 2, 2005
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: Darren Schofield, Suzanne U. Emerson, Robert H. Purcell, Harvey J. Alter
  • Monoclonal antibodies specific for the e2 glycoprotein of hepatitic c virus and their use in the diagnosis, treatment , and prevention of hepatitis c
    Publication number: 20040115619
    Abstract: The present invention describes the identification and characterization of five human HC E2-specific monoclonal antibodies isolated form a phage display library and their use in the diagnosis, treatment, and prevention of HCV in mammals, preferably humans.
    Type: Application
    Filed: December 15, 2003
    Publication date: June 17, 2004
    Inventors: Darren Schofield, Suzanne U Emerson, Robert H Purcell, Harvey J Alter